News
BLFS
35.07
-0.45%
-0.16
BioLife Solutions Cut to Hold From Buy by Benchmark
Dow Jones · 5d ago
Benchmark Downgrades BioLife Solutions to Hold
Benzinga · 5d ago
BioLife Solutions downgraded to Hold from Buy at Benchmark
TipRanks · 5d ago
Weekly Report: what happened at BLFS last week (0803-0807)?
Weekly Report · 5d ago
Analysts Offer Insights on Healthcare Companies: IN8bio (INAB), Lineage Therap (LCTX) and BioLife Solutions (BLFS)
TipRanks · 08/07 15:00
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Korro Bio (KRRO), Electrocore (ECOR) and BioLife Solutions (BLFS)
TipRanks · 08/07 13:20
BioLife Solutions, Inc. FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2026
Press release · 08/07 01:33
*BioLife Solutions 2Q Rev $28.5M >BLFS
Dow Jones · 08/06 20:03
Press Release: BioLife Solutions Reports Second Quarter 2026 Financial Results
Dow Jones · 08/06 20:03
*BioLife Solutions 2Q EPS 91c >BLFS
Dow Jones · 08/06 20:03
Diamond Hill Small Cap Fund Q2 2026 Portfolio Activity
Seeking Alpha · 08/05 18:05
BioLife Details Strategic Repligen Merger Communication to Staff
TipRanks · 08/03 22:21
Weekly Report: what happened at BLFS last week (0727-0731)?
Weekly Report · 08/03 10:16
Repligen: Acquisition To Add Cell Therapy Capabilities
Seeking Alpha · 08/02 15:50
BioLife Solutions Up Over 10%, on Track for Highest Close Since January 2022 -- Data Talk
Dow Jones · 07/28 15:34
BioLife Solutions Price Target Cut to $31.00/Share From $32.00 by Stephens & Co.
Dow Jones · 07/27 17:35
BioLife Solutions Cut to Equal-Weight From Overweight by Stephens & Co.
Dow Jones · 07/27 17:35
Stephens & Co. Downgrades BioLife Solutions to Equal-Weight, Lowers Price Target to $31
Benzinga · 07/27 17:24
BioLife Solutions downgraded to Equal Weight from Overweight at Stephens
TipRanks · 07/27 11:55
Weekly Report: what happened at BLFS last week (0720-0724)?
Weekly Report · 07/27 10:20
More
Webull provides a variety of real-time BLFS stock news. You can receive the latest news about Biolife Solutions Inc through multiple platforms. This information may help you make smarter investment decisions.
About BLFS
BioLife Solutions, Inc. is a developer and supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during the collection, development, manufacturing and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the cell and gene therapy market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal closed systems are purpose-built rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company's ThawSTAR product line comprises a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.